Therapeutic development of polymers for prion disease

Area of Science:

• Neuroscience
• Biochemistry
• Polymer Science

Background:

• Prion diseases, or transmissible spongiform encephalopathies, stem from abnormal prion protein (PrPSc) accumulation in the central nervous system.
• Conventional drug development strategies may be insufficient due to the unique aggregation and structural transformation of prions.

Purpose of the Study:

• To review the historical application of polymers in prion disease research.
• To describe polymers exhibiting anti-prion activity and discuss their common characteristics.
• To highlight the potential of polymers as therapeutic leads and research tools for prion diseases.

Main Methods:

• Overview of historical polymer applications in prion disease research.
• Description and characterization of various polymers with anti-prion activity.
• Discussion of common features among effective anti-prion polymers.

Main Results:

• Numerous compounds, including various polymers, have demonstrated anti-prion activities.
• Polymers present distinct therapeutic strategies beyond conventional methods for prion diseases.
• Polymers are valuable for studying PrPSc structure and developing new anti-prion therapies.

Conclusions:

• Polymers are crucial tools in prion disease research, aiding in understanding PrPSc structure.
• Despite challenges in brain drug delivery, polymers serve as essential leads for developing novel anti-prion therapeutics.
• The unique nature of prions necessitates innovative therapeutic approaches, where polymers play a significant role.